Pharmaceutical Supply – Omeprazole Extended-Release Capsules

The contract entails the manufacture and supply of FDA-approved omeprazole extended-release capsules in bottle packaging, strictly adhering to USP standards and bearing the designated NDC number 00186-0742-31 and CAGE code 1AK01. This is a subcontract under the Defense Logistics Agency, part of the Department of Defense, and falls under the NAICS code 325412 for pharmaceutical and biological product manufacturing. The product must meet all regulatory requirements for safety, efficacy, and labeling to ensure compliance with U.S. pharmaceutical regulations and military supply chain specifications. The agreement is positioned for delivery under the contract vehicle SPE2DP26F7671, with the solicitation posted on July 14, 2026, indicating a forward-looking procurement timeline. Although details such as the quantity, delivery schedule, payment terms, and performance location are not specified in the provided data, the contract is intended to support critical pharmaceutical needs within the DoD’s healthcare logistics system. The absence of set-aside information suggests this may be open to qualified manufacturers without restrictions based on business size or category. All supplied capsules must be consistently manufactured, packaged, and labeled to maintain batch integrity and regulatory approval throughout their lifecycle.